A meta-analysis has demonstrated that selenium supplementation in HT patients treated with levothyroxine reduced serum TPO antibody levels after 3, 6, and 12 months, but a reduction was seen only at 3 months and not at 6 and 12 months in untreated HT patients [15]. Here, TPO is linked to hematocrit.